The protective effects of Radix Astragali and Rhizoma Ligustici Chuanxiong on endothelial dysfunction in type 2 diabetic patients with microalbuminuria

Journal of Sichuan University (Medical Science)

Volumn 36, Issue 4, 2005, Pages 529-532

  Lu, Zhi Ming ^a   Yu, Ye Rong ^a   Tang, Hong ^a   Zhang, Xiang Xun ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Endothelial dysfunction; Microalbuminuria; Radix Astragali; Rhizoma Ligustici Chuanxiong; Type 2 diabetes

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CREATININE; GLYCERYL TRINITRATE; HERBACEOUS AGENT; MALONALDEHYDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RADIX ASTRAGALI EXTRACT; RHIZOMA LIGUSTICI EXTRACT; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTERY DIAMETER; ARTERY INTIMA PROLIFERATION; ARTICLE; ASTRAGALUS PLANT; BRACHIAL ARTERY; CLINICAL ARTICLE; COMMON CAROTID ARTERY; FIBRINOLYSIS; HUMAN; HYPEREMIA; MEDICINAL PLANT; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; RADIX ASTRAGALI; RHIZOMA LIGUSTICI; RHIZOME; THROMBOSIS; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 23244449231     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med, 2001;345: 861.
2. Tan KC, Chow WS, Ai VH, et al. Effects of angiotensin I receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria. Diabetes Metab Res Rev, 2002;18(1):71.
3. Juhan-Vague I, Alessi MC. Fibrinolysis and risk of coronary artery disease. Fibrinolysis, 1996;10:127.
4. Yu YR, Suo LX, Yu HL, et al. Insulin resistance and endothelial dysfunction in type 2 diabetes patients with or without microalbumin uria. Diabetes Res Clin Pract, 2004;65: 95.
5. Andreas Festa, Ralph D'agostino Jr, George Howard, et al. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subject: The insulin resistance atherosclerosis study. Kidney International, 2000;58:1703.
6. Koenig W, Sund M, Frohlich M, et al. C-reactive protein, a sensitive marker of inflammation, predict future risk of coronary heart disease in initially healthy middle-aged men. Circulation, 1999;99:237.